MedicalResearch.com Interview with:
Yana Vinogradova, PhD
Department of Primary Care
School of Medicine
University of Nottingham
University Park, Nottingham
MedicalResearch.com: What is the background for this study?
Response: The study targeted middle age women going through menopause. This is the stage of life when women naturally reach the end of their reproductive life and their hormones gradually decrease. Some women experience unpleasant effects such as hot flushes, night sweats, mood swings, memory and concentration loss, headaches. Quality of life may be severely affected. Hormone replacement therapy uses a class of drugs, which, like all drugs, have side effects. VTE is a serious side effect which can have a lethal outcome.
There are different preparations of hormones available for such women. Some of them were extensively studied in a large American Trial Women’s Health Initiative and showed the risk of VTE to be twice as high for women who took them. However, these well-studied drugs are mostly prescribed in America. The more popular drugs in Europe and the UK have been much less studied, so it was unclear how they compared. Continue reading